早期小细胞肺癌患者未接受预防性颅脑照射时接受手术或放疗的临床结局:单中心回顾性研究
该单中心回顾性研究纳入2015年7月至2021年5月诊断的14例早期(T1-T2)小细胞肺癌患者,6例接受立体定向体部放疗(SBRT)、8例接受手术,均未行预防性颅脑照射(PCI)。中位随访14.3个月,手术与SBRT组各项结局均无显著差异,研究期间无患者发生脑转移;作者指出样本量过小不足以得出结论。
要点
- 14例早期小细胞肺癌中6例接受SBRT、8例接受手术,均未行PCI。
- 手术与SBRT组在局部区域复发、远处复发、无复发生存和总生存上均无显著差异。
- 研究期间无患者发生脑转移;作者指出样本量过小不足以得出结论。
核心结论
- 早期小细胞肺癌是否受益于PCI缺乏数据,本研究样本量过小不足以得出结论,但为PCI在该人群中的重要性的讨论提供了资料。
- 未行PCI时接受手术或SBRT的患者在生存和肿瘤复发方面未见差异。
研究设计与样本
- 单中心回顾性研究,纳入2015年7月至2021年5月在一家三级医院诊断的14例早期(T1-T2)小细胞肺癌患者,接受SBRT或手术且未行PCI。
- 主要结局为局部区域肿瘤复发、远处复发、无复发生存和总生存,次要结局为脑转移发生;分析采用Cox回归、Kaplan-Meier生存分析和log-rank检验。
主要发现
- 共14例患者(女5例、男9例),T1期9例、T2期5例;6例(43%)接受SBRT,8例(57%)接受手术。
- 除1例外所有患者接受辅助化疗;中位随访14.3个月(范围2.4-64.4个月),诊断时中位年龄71.5岁(范围54-81岁)。
- Cox回归和log-rank检验显示手术组与SBRT组在任何结局上均无显著差异,研究期间无患者发生脑转移。
临床怎么用
- 原文未据此给出推荐。
- 作者认为,尽管本研究样本量过小不足以得出结论,上述发现为早期小细胞肺癌中PCI重要性的持续讨论增添了资料。
局限性
- 本研究为单中心回顾性研究。
- 作者指出本研究样本量过小,不足以得出任何结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: As screening chest computed tomography for patients at high risk for cancer has become more widely accepted, increasing numbers of patients with early-stage small cell lung cancer (SCLC) are being diagnosed. Although surgery is an accepted option for patients with early-stage SCLC, for patients who decline or cannot undergo surgery, stereotactic body radiation treatment (SBRT) is an alternative. Although prophylactic cranial irradiation (PCI) improves survival in patients with limited-stage SCLC, PCI for early-stage SCLC (stage T1-T2) has not been explored. This study defines survival and recurrence patterns in patients with early-stage SCLC who were treated with surgery or SBRT in the absence of PCI. METHODS AND MATERIALS: In this single-institution retrospective study, 14 patients diagnosed with early-stage SCLC (stage T1-T2) between July 2015 and May 2021 at a single tertiary care hospital were treated with SBRT or surgery with no PCI. Primary outcomes were locoregional cancer recurrence, distant recurrence, recurrence-free survival, and overall survival. The secondary outcome was development of brain metastasis. Analyses included Cox regression, Kaplan-Meier survival, and log-rank tests. RESULTS: A total of 14 patients (5 women and 9 men) were included in the study: 9 with stage T1 and 5 with stage T2 SCLC. Six patients (43%) received SBRT and 8 (57%) had surgical treatment. All patients except 1 received adjuvant chemotherapy. Median follow-up was 14.3 months (range, 2.4-64.4 months), and the median age at diagnosis was 71.5 years (range, 54-81 years). Cox regression and log-rank tests showed no significant differences in any outcomes between the surgery and SBRT groups, and no patients developed brain metastases during the study period. CONCLUSIONS: Data are lacking regarding the benefit of PCI in early-stage SCLC. Although the sample size in this study was too small to draw any conclusions, the findings add to the ongoing dialogue regarding the importance of PCI in this patient population. No difference was identified in survival and cancer recurrence in patients who received either surgery or SBRT in the absence of PCI.
引用
- Khatib SA, Adil K, Schultz L, et al. Clinical Outcome in Patients With Early-Stage Small Cell Lung Cancer Treated With Surgery or Radiation in the Absence of Prophylactic Cranial Irradiation: A Single-Center Retrospective Study. Adv Radiat Oncol. 2023. PMID: 37152487. doi:10.1016/j.adro.2023.101190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。